Live tape
Top 8, mentions 7d10,506TSLA2,132 mentions▲ +0.05GOOGL1,646 mentions▲ +0.04CRWV1,305 mentions▲ +0.03NVDA1,270 mentions▲ +0.07SPCX1,164 mentions▲ +0.07QQQ1,139 mentions▲ +0.05META941 mentions▲ +0.05NBIS909 mentions▲ +0.05

Equity · Healthcare

BBIO

NASDAQ

BridgeBio Pharma, Inc.

$66 −1.49% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026

Reddit mentioned BBIO 1 times in the 30 days to 19 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 19 October 2026.

Price · Chart
63 sessions
$90 $60 21 Jul 16 Oct

The line runs $82 on 21 July through $66 on 16 October, on a scale from $60 to $90. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
Market cap $12.9B
52-week range $53 – $90
Avg volume 160.3K
Mentions · 30d 1

as of Oct 16, 2026

BBIO · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Day7 Oct 2026

MENTIONS10–2 / day
PRICE$66.49$62–$70
BBIO over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day012usd$62$64$66$68$7020 Sep27 Sep5 Oct12 Oct19 Oct
BBIO over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.20 Sep5 Oct19 Oct
The Distributed Sentinel 19 Oct 2026

BBIO drew 1 Reddit mentions over the 30 days to 19 October 2026

This chart in words

The chart plots daily Reddit mentions of BBIO over the 30 days to 19 October 2026: 1 in total, busiest on 7 October with 1, and 1 on the last day counted. The line is the daily close over the same window: $66.55 on 21 September, $66 on 16 October. Of those days, 20 were trading sessions and the other 10 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them no session took place, and this window holds no earlier close to carry forward; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Crowd sentiment on BBIO · 30d

n = 1 scored · Method

1 mention of BBIO was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where BBIO is discussed

(30d)
r/stocks 100% 1 +0.20

BBIO insider trades

SEC Form 4 · last 90 days · newest reported trade 17 Sep 2026
Open-market buys 0
Open-market sells 4
Net sold $4.58M
Non-trade filings 4
Date Insider Type Shares Value
17 Sep 2026 Kumar Neil Chief Executive Officer Sell 10,000 $691K
19 Aug 2026 Kumar Neil Chief Executive Officer Sell 10,000 $840K
18 Aug 2026 Kumar Neil Chief Executive Officer Sell 34,980 $2.89M
30 Jul 2026 Apuli Maricel Chief Accounting Officer Sell 2,000 $160K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
16 Aug 2026 Apuli Maricel Chief Accounting Officer Tax withheld 4,714 $376K
16 Aug 2026 Kumar Neil Chief Executive Officer Option exercise 71,217
16 Aug 2026 Kumar Neil Chief Executive Officer Tax withheld 36,237 $2.89M
16 Aug 2026 Trimarchi Thomas President and CFO Tax withheld 22,781 $1.82M

BBIO reported financials

SEC EDGAR XBRL SEC EDGAR

BBIO reported revenue of $502.1M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$724.9M.

Figure Reported Period
Revenue $502.1M 31 Dec 2025 fiscal year
Net income to common shareholders −$724.9M 31 Dec 2025 fiscal year
Diluted EPS −$3.78 31 Dec 2025 fiscal year
Total assets $1.2B 30 Jun 2026 at period end
Total equity −$2.5B 30 Jun 2026 at period end

BBIO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.78 $244M
31 Mar 2026 Q1 2026 −$0.84 $195M
31 Dec 2025 FY 2025 −$3.78 $502M
30 Sep 2025 Q3 2025 −$0.95 $121M
30 Jun 2025 Q2 2025 −$0.95 $111M
31 Mar 2025 Q1 2025 −$0.88 $117M
31 Dec 2024 FY 2024 −$2.88 $222M
30 Sep 2024 Q3 2024 −$0.86 $3M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BBIO institutional holders

SEC Form 13F SEC EDGAR

14 of the 45 institutional funds we track reported a BBIO position for the quarter ended 30 Jun 2026 — a combined $2.0B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Viking Global Investors Held (±25%) −16.0% shares 9,949,219 $741.0M
Two Sigma Investments Added +51.3% shares 4,722,185 $351.7M
Citadel Advisors Held (±25%) +18.5% shares 3,760,028 $280.0M
D. E. Shaw & Co. Added +42.7% shares 3,633,007 $270.6M
Point72 Asset Management New position 1,525,782 $113.6M
Balyasny Asset Management Added +251.3% shares 1,230,052 $91.6M
Renaissance Technologies Added +134.3% shares 856,846 $63.8M
Millennium Management Held (±25%) −23.0% shares 487,594 $36.3M
Bridgewater Associates Added +72.7% shares 448,143 $33.4M
Fisher Asset Management Held (±25%) −1.8% shares 345,351 $25.7M

Showing the 10 largest of 14 reported positions. The figures above count all of them.

BBIO fails-to-deliver

SEC CNS data SEC

On 18 Sep 2026, 5,445 shares of BBIO failed to deliver (about $367K).

Settlement date Shares failed Notional % of shares out
18 Sep 2026 5,445 $367K 0.003%
14 Sep 2026 50,173 $3.6M 0.026%
11 Sep 2026 105 $8K <0.001%
10 Sep 2026 283 $22K <0.001%
08 Sep 2026 2 $150 <0.001%
04 Sep 2026 123 $9K <0.001%

Congressional trades in BBIO

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in BBIO is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 29 Sep 2026.

Date Member Type Amount
29 Sep 2026 filed 12 Oct 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K
11 May 2026 filed 08 Jun 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
19 Mar 2026 filed 07 Apr 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
22 Sep 2025 filed 10 Oct 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
08 Aug 2025 filed 12 Sep 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K

BBIO — frequently asked questions

From live data

Is Reddit bullish or bearish on BBIO?

Across 1 classified BBIO mentions in the last 30 days, 100% read bullish, 0% bearish and 0% neutral. Crowd sentiment is a social signal, not investment advice.

When did BBIO last report earnings?

BridgeBio Pharma (BBIO) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are BBIO insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 4 sells by BBIO insiders on the open market. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is BBIO listed on?

BridgeBio Pharma trades on NASDAQ under the ticker BBIO.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings